Health Policy & Law Daily 2022: Latest News and Regulatory Developments from the FDA and U.S. Government - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Health Policy & Law Daily" newsletter has been added to ResearchAndMarkets.com's offering.
Health Policy & Law Daily focuses on the latest news and regulatory developments from the FDA and U.S. government concerning food products, medical devices, pharmaceuticals, biotechnology, medical practice, hospitals, and more. Legal counsel, physicians, and health professionals can also learn about ongoing lawsuits, contract negotiations, and settlements in the health, medical, and pharmaceutical fields.
For over 30 years, the analyst has monitored and reported on the world's emerging research and discoveries every day. With decades of reporting experience, we understand that great journalism demands transparent sourcing and journalistic integrity. Our original content is reported from sources of unparalleled depth according to the highest standards of journalism.
An annual subscription includes new issues Monday through Friday, 52 weeks out of the year.
For more information about this newsletter visit https://www.researchandmarkets.com/r/emfzlo
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Editor Details
-
Company:
- Businesswire
